|
The Oncovation companies have pioneered innovative,
inter-disciplinary approaches to utilizing evidence-based medicine to
develop targeted treatments for cancer.
Exploring the mechanisms and pathways of disease, together with the unique
characteristics of the individual, can accelerate the prevention, detection
and cure of disease. Along with the obvious individual benefits of increased
survival and improved quality of life for patients, "personalized or
evidence-based" medicine also greatly enhances the potential economic
profile of drugs based on greater and more predictable efficacy.
Scientific advances in areas such as proteomics, combinational chemistry and
genetics are ushering in an era where patient care, from diagnosis through
treatment, will be tailored to the individual. The convergence of patient
screening, patient care and drug development are being projected as the
expected fruits of the genomic revolution. Oncovation, however, does not
believe the revolution is years away. Oncovation companies leverage their
proprietary technologies and methodologies and particular expertise in drug
interaction to offer this heralded functionality today.
|
|
|
www.oncovationpharma.com |
|
|
Oncovation Pharmaceuticals utilizes its proprietary methodologies to identify and develop next generation partner drugs for chemotherapy. Along with developing novel compounds targeting solid tumors, we reposition “once promising” therapeutics that were abandoned or failed further along in the development process. Our strategy includes in-licensing and developing proprietary compounds that are likely chemopotentiators for current chemotherapies targeting cancer. |
|
|
|
|
 |
|
www.oncovationlabs.com |
|
|
Oncovation Laboratories is an
innovative laboratory services company focusing on cancer. Our
diagnostics group provides patients and the medical
community with patient specific tumor chemoresponse
information that allows oncologists to select and, if
necessary, devise individualized treatment protocols. Through
our clinical services group we provide pre-clinical and
Phase I-IV drug development services to the global
pharmaceutical and biotechnology industries. |
|
|
|
